CYTARABINE-INDUCED KERATOCONJUNCTIVITIS: A COMMON COMPLICATION OF HIGH DOSE THERAPY FOR ACUTE MYELOID LEUKEMIA

Title CYTARABINE-INDUCED KERATOCONJUNCTIVITIS: A COMMON COMPLICATION OF HIGH DOSE THERAPY FOR ACUTE MYELOID LEUKEMIA
Author, Co-Author Katherine Schmidt
Topic Residents Day
Year
2016
Day
Saturday
Program Number
R2016168
Room
Ballroom A-B
Affiliation
New England College of Optometry
Abstract Here we describe a case of cytarabine ocular toxicity in a patient with acute myeloid leukemia. Keratoconjunctivitis is a well-described side effect in the hematology/oncology literature. Prophylactic topical steroids are typically initiated, with variable efficacy.
Affiliation of Co-Authors
Outline Katherine_Schmidt.pdf